Is MBX Biosciences, Inc. Common Stock overvalued?

MBX Biosciences, Inc. Common Stock (MBX) — key valuation metrics and fundamentals.

No verdict

Price

$55.94

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.78B

Dividend yield

0.0%

Return on equity

-34.4%

Sector

Healthcare

Fair value compares MBX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks